DiscoverWCG Talks TrialsWCG's IRB Policy Change: Harmonizing Consent (Part 2)
WCG's IRB Policy Change: Harmonizing Consent (Part 2)

WCG's IRB Policy Change: Harmonizing Consent (Part 2)

Update: 2024-02-27
Share

Description

In Part 2 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses new FDA regulations for waiver of consent with Kelly Fitzgerald, PhD, WCG's IRB Executive Chair and VP IBC Affairs. 

Comments 
In Channel
Advancing Access: How SaaS is Transforming Clinical Trials

Advancing Access: How SaaS is Transforming Clinical Trials

2025-08-2623:22

Advancing Imaging in Clinical Trials Using AI

Advancing Imaging in Clinical Trials Using AI

2025-08-0621:12

Future-Ready Research: Optimizing Sites for Continued Success

Future-Ready Research: Optimizing Sites for Continued Success

2025-06-2020:42

Harnessing Generative AI in Clinical Research

Harnessing Generative AI in Clinical Research

2025-05-2823:42

AI in Clinical Trials: Unlocking the Potential

AI in Clinical Trials: Unlocking the Potential

2025-03-1827:54

Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials

Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials

2025-02-2425:44

From Patient Care to Discovery: A Clinician's Journey into Research

From Patient Care to Discovery: A Clinician's Journey into Research

2024-12-1019:45

Inside MAGI: Innovation, Education, and Industry Trends

Inside MAGI: Innovation, Education, and Industry Trends

2024-11-2529:19

Revolutionizing Clinical Research Through Collaboration and Innovation

Revolutionizing Clinical Research Through Collaboration and Innovation

2024-11-0728:54

Have a Safe Trip: Clinical and Patient Alignment in Research with Psychedelics

Have a Safe Trip: Clinical and Patient Alignment in Research with Psychedelics

2024-10-0723:27

Breaking Barriers: Reasons to Expand Site Cancer Trial Portfolios

Breaking Barriers: Reasons to Expand Site Cancer Trial Portfolios

2024-09-1828:53

Patient Advocacy Advancing Breakthrough Science and Community Engagement

Patient Advocacy Advancing Breakthrough Science and Community Engagement

2024-09-1628:54

Guarding Research Integrity: The IRB's Essential Role

Guarding Research Integrity: The IRB's Essential Role

2024-09-1327:27

Addressing Challenges in Site Feasibility

Addressing Challenges in Site Feasibility

2024-08-3020:14

Ethical Review and AI in Clinical Trials

Ethical Review and AI in Clinical Trials

2024-06-2139:43

Addressing Measurement Challenges for PTSD Trials with Technology

Addressing Measurement Challenges for PTSD Trials with Technology

2024-06-1121:40

What Is E-Consent? Interview with Erin Brower

What Is E-Consent? Interview with Erin Brower

2024-04-1109:35

Creating Partnerships: Aligning Vendor Support for Success in Clinical Research

Creating Partnerships: Aligning Vendor Support for Success in Clinical Research

2024-03-0620:56

WCG's IRB Policy Change: Harmonizing Consent (Part 2)

WCG's IRB Policy Change: Harmonizing Consent (Part 2)

2024-02-2708:06

WCG's IRB Policy Change: Harmonizing Consent (Part 1)

WCG's IRB Policy Change: Harmonizing Consent (Part 1)

2024-02-2706:06

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

WCG's IRB Policy Change: Harmonizing Consent (Part 2)

WCG's IRB Policy Change: Harmonizing Consent (Part 2)

WCG